| Symbol | MDXXF |
|---|---|
| Name | PHARMALA BIOTECH HOLDINGS INC. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | M5C 1P1 Canada ON 82 Richmond St. E |
| Telephone | +1 855-444-6362 |
| Fax | — |
| — | |
| Website | https://pharmala.ca/ |
| Incorporation | CA |
| Incorporated On | 2021 |
| Employees | — |
| Fiscal Year | 8/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Clearhouse LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: Canadian Securities Exchange |
| CIK | — |
| Description | Pharmala is focused on manufacture of Active Pharmaceutical Ingredients, of the Substituted methylenedioxy- phenethylamines class ("MDXX"), including 3,4-Methylenedioxymethamphetamine ("MDMA"). Pharmala also intends to undertake development of Additional info from OTC: |
No news found.